These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21631283)

  • 41. Reproductive factors, menopausal hormone therapy, and risk of non-Hodgkin, diffuse large B-cell and follicular lymphomas: a UK case-control study.
    Mildon KH; Ansell P; Roman E; Kane EV
    Cancer Causes Control; 2010 Dec; 21(12):2079-83. PubMed ID: 20697798
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of JAK-STAT pathway related genes with lymphoma risk: results of a European case-control study (EpiLymph).
    Butterbach K; Beckmann L; de Sanjosé S; Benavente Y; Becker N; Foretova L; Maynadie M; Cocco P; Staines A; Boffetta P; Brennan P; Nieters A
    Br J Haematol; 2011 May; 153(3):318-33. PubMed ID: 21418178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of polymorphisms in BCL-2 and BAX genes in modulating the risk of developing non-Hodgkin lymphoma.
    Wang WL; Tao YP; Han XL; Li X; Zi YM; Yang C; Li JD
    Leuk Lymphoma; 2014 Jul; 55(7):1602-8. PubMed ID: 24024471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polymorphisms of drug-metabolizing enzymes CYP1A1, GSTT and GSTP contribute to the development of diffuse large B-cell lymphoma risk in the Saudi Arabian population.
    Al-Dayel F; Al-Rasheed M; Ibrahim M; Bu R; Bavi P; Abubaker J; Al-Jomah N; Mohamed GH; Moorji A; Uddin S; Siraj AK; Al-Kuraya K
    Leuk Lymphoma; 2008 Jan; 49(1):122-9. PubMed ID: 18203021
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polymorphisms in cytochrome P450 17A1 and risk of non-Hodgkin lymphoma.
    Skibola CF; Lightfoot T; Agana L; Smith A; Rollinson S; Kao A; Adamson P; Morgan GJ; Smith MT; Roman E
    Br J Haematol; 2005 Jun; 129(5):618-21. PubMed ID: 15916684
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polymorphisms in DNA repair pathway genes, body mass index, and risk of non-Hodgkin lymphoma.
    Chen Y; Zheng T; Lan Q; Kim C; Qin Q; Foss F; Chen X; Holford T; Leaderer B; Boyle P; Wang C; Dai M; Liu Z; Ma S; Chanock SJ; Rothman N; Zhang Y
    Am J Hematol; 2013 Jul; 88(7):606-11. PubMed ID: 23619945
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methylenetetrahydrofolate reductase C677T polymorphism in adult patients with lymphoproliferative disorders and its effect on chemotherapy.
    Timuragaoglu A; Dizlek S; Uysalgil N; Tosun O; Yamac K
    Ann Hematol; 2006 Dec; 85(12):863-8. PubMed ID: 16944145
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical and pathological reassessment of 493 cases of non-Hodgkin's lymphomas according to current WHO classification of lymphoid neoplasms].
    Xiao C; Su ZL; Wu QL; Gao HY; Fang JC; Xia ZJ; Guan ZZ
    Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):22-7. PubMed ID: 15796877
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East.
    Siraj AK; Ibrahim M; Al-Rasheed M; Bu R; Bavi P; Jehan Z; Abubaker J; Murad W; Al-Dayel F; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K
    Ann Hematol; 2007 Dec; 86(12):887-95. PubMed ID: 17712558
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Gene Polymorphism of Inflammation-related Cytokines Correlates with the Susceptibility to DLBCL].
    Tian CP; Liao SQ; Yuan HX; Yao BC; Wang F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):444-448. PubMed ID: 28446290
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
    Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of cytotoxic T-lymphocyte antigen 4 genetic polymorphism, hepatitis C viral infection and B-cell non-Hodgkin lymphoma: an Egyptian study.
    Khorshied MM; Gouda HM; Khorshid OM
    Leuk Lymphoma; 2014 May; 55(5):1061-6. PubMed ID: 23829277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association analysis between the Cdc6 G1321A polymorphism and the risk for non-Hodgkin lymphoma and hepatocellular carcinoma.
    Xiong XD; Qiu FE; Fang JH; Shen Y; Liang C; Jiang W; Zhuang SM
    Mutat Res; 2009 Mar; 662(1-2):10-5. PubMed ID: 19101572
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The association between hepatitis C virus infection, genetic polymorphisms of oxidative stress genes and B-cell non-Hodgkin's lymphoma risk in Egypt.
    Farawela H; Khorshied M; Shaheen I; Gouda H; Nasef A; Abulata N; Mahmoud HA; Zawam HM; Mousa SM
    Infect Genet Evol; 2012 Aug; 12(6):1189-94. PubMed ID: 22522002
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Polymorphisms in cytokine genes as prognostic markers in diffuse large B cell lymphoma patients treated with (R)-CHOP.
    Liu D; Wang Y; Dong M; Guan S; Wang Y; Sun H; Wu N; Li S; Bai J; Chen F; Sun D; Jin Y
    Ann Hematol; 2017 Feb; 96(2):227-235. PubMed ID: 27822610
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic susceptibility to diffuse large B-cell lymphoma in a pooled study of three Eastern Asian populations.
    Bassig BA; Cerhan JR; Au WY; Kim HN; Sangrajrang S; Hu W; Tse J; Berndt S; Zheng T; Zhang H; Pornsopone P; Lee JJ; Kim HJ; Skibola CF; Vijai J; Burdette L; Yeager M; Brennan P; Shin MH; Liang R; Chanock S; Lan Q; Rothman N
    Eur J Haematol; 2015 Nov; 95(5):442-8. PubMed ID: 25611436
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genotype study of non-Hodgkin's lymphoma.
    Pitera R; Pitera JE; Mufti GJ; Salisbury JR
    Pathol Res Pract; 1995 Jun; 191(5):444-55. PubMed ID: 7479363
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of sequence polymorphisms in the D-loop region of mitochondrial DNA as a risk factor for non-Hodgkin lymphoma.
    Gao Y; Zhao G; Diao L; Guo Z
    Mitochondrial DNA; 2014 Jun; 25(3):220-2. PubMed ID: 23795851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional interleukin-21 polymorphism is a protective factor of diffuse large B-cell lymphoma.
    Wang H; Wang M; Feng Z; Chen L; Gao L; Li Q; Zhang L; Ma J
    DNA Cell Biol; 2014 Nov; 33(11):775-80. PubMed ID: 25126827
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Integrating understanding of epidemiology and genomics in B-cell non-Hodgkin lymphoma as a pathway to novel management strategies.
    Glass S; Phan A; Williams JN; Flowers CR; Koff JL
    Discov Med; 2016 Mar; 21(115):181-8. PubMed ID: 27115168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.